Model
Edge
Alnylam Pharmaceuticals, Inc.
0001511797
Filing Type
3
Filing Date
9/21/2025
Updated
9/22/25, 2:04 PM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership